Science Explorer Back to mapMap
Discussion
Institution · MBC Pharma (United States)

Most cited papers from MBC Pharma (United States)

MBC Pharma (United States)

What are the most cited papers from MBC Pharma (United States)?

The most cited paper from MBC Pharma (United States) is "Bisphosphonate conjugation for bone specific drug targeting" (Kristen B. Farrell, Alexander M. Karpeisky, Douglas H. Thamm et al., 2018), with 183 citations. Next come "The promise of Immuno-oncology: implications for defining the value of cancer treatment" (115) and "Colorado Medical Students’ Attitudes and Beliefs About Marijuana" (81).

Showing 26 of 26 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Bisphosphonate conjugation for bone specific drug targeting Kristen B. Farrell, Alexander M. Karpeisky, Douglas H. Thamm et al. · Bone Reports Open access 2 Jul 2018 183
2 The promise of Immuno-oncology: implications for defining the value of cancer treatment Howard L. Kaufman, Michael B. Atkins, Prasun Subedi et al. · Journal for ImmunoTherapy of Cancer Open access 17 May 2019 115
3 Colorado Medical Students’ Attitudes and Beliefs About Marijuana Michael Chan, Christopher E. Knoepke, Madeline L. Cole et al. · Journal of General Internal Medicine Open access 17 Jan 2017 81
4 Phase 1 Single‐ and Multiple‐Ascending‐Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG‐348, a First‐in‐Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers Hua Qiang Yang, Elizabeth Merica, Yue Chen et al. · Clinical Pharmacology in Drug Development 9 Aug 2018 57
5 A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites Monica Madden Reinholz et al. · Bone Open access 16 Mar 2010 40
6 Brain Mitochondrial Drug Delivery: Influence of Drug Physicochemical Properties Shelley A. Durazo, Rajendra S. Kadam, Derek A. Drechsel et al. · Pharmaceutical Research Open access 27 Jul 2011 35
7 First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease Shawn Patrick Zinnen, Alexander M. Karpeisky, Daniel D. Von Hoff et al. · The Oncologist Open access 9 Nov 2018 17
8 3D electron tomographic and biochemical analysis of ER, Golgi and trans Golgi network membrane systems in stimulated Venus flytrap (Dionaea muscipula) glandular cells Zachary R. Gergely, Dana E. Martínez, Bryon S. Donohoe et al. · Journal of Biological Research - Thessaloniki Open access 8 Aug 2018 15
9 Bisphosphonate Derivatives of Nucleoside Antimetabolites: Hydrolytic Stability and Hydroxyapatite Adsorption of 5′-β,γ-Methylene and 5′-β,γ-(1-Hydroxyethylidene) Triphosphates of 5-Fluorouridine and ara-Cytidine Mikko Ora, Tuomas Lönnberg, Diana Florea‐Wang et al. · The Journal of Organic Chemistry 13 May 2008 15
10 Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication Roger Lewis, Jason T. Connor, John R. Teerlink et al. · Trials Open access 25 May 2011 9
11 Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study Rachael F. Grace et al. · Blood 2 Dec 2016 6
12 Gemcitabine–Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel Kristen B. Farrell, Shawn Patrick Zinnen, Douglas H. Thamm et al. · Bioconjugate Chemistry Open access 15 Nov 2021 5
13 Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants Bin Fan, David L. Dai, Marvin B. Cohen et al. · Clinical Pharmacology in Drug Development 9 Jul 2020 4
14 StrandAdvantage test for early‐line and advanced‐stage treatment decisions in solid tumors Manimala Sen et al. · Cancer Medicine Open access 3 Apr 2017 4
15 Evaluation of a novel bone targeted aracytidine therapy in dogs with spontaneous osteosarcoma Shawn Patrick Zinnen, Doug Thamm, David M. Vail et al. · Bone 22 Dec 2010 4
16 Population Pharmacokinetics and Pharmacodynamics of AG-348 in Healthy Human Volunteers Guide Dose Selection for the Treatment of Pyruvate Kinase Deficiency Kha N. Le, Marvin B. Cohen, Yue Chen et al. · Blood 3 Dec 2015 3
17 Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency Rachael F. Grace, David Mark Layton, F. Galactéros et al. · Blood 7 Dec 2017 2
18 Phase I Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase-R, in Healthy Subjects Hua Qiang Yang, Elizabeth Merica, Yue Chen et al. · Blood 6 Dec 2014 2
19 Effect of helix length on the stability of the lac repressor antiparallel coiled coil Wheaton Little, James P. Robblee, Caroline L. Dahlberg et al. · Biopolymers 13 May 2015 2
20 Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs Jost Klawitter, Mckay Easton, Alexander M. Karpeisky et al. · Molecules Open access 16 Jan 2025 1
21 Cannabidiol for treatment of Irritability and Aggressive Behavior in Children and Adolescents with ASD: Background and Methods of the CAnnabidiol Study in Children with Autism Spectrum DisordEr (CASCADE) Study Elise M. Sannar, Joan R. Winter, Ronda K. Franke et al. · medRxiv PreprintOpen access 13 Aug 2024 1
22 DRIVE PK: A Phase 2 Trial of AG-348 in Patients with Pyruvate Kinase Deficiency Ann Barbier, Bruce A. Silver, Elizabeth Merica et al. · Blood 3 Dec 2015 1
23 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of AG-519, an Allosteric Activator of Pyruvate Kinase-R, in Healthy Subjects Ann Barbier, Susan Bodie, Gary Connor et al. · Blood 2 Dec 2016 0
24 Population Pharmacokinetics and Pharmacodynamics of AG-519, a Pyruvate Kinase Activator for the Treatment of Pyruvate Kinase Deficiency, in Human Healthy Volunteers Kha N. Le, Marvin B. Cohen, Ann Barbier et al. · Blood 2 Dec 2016 0
25 The Effect of Spices and Herbs on Acceptance of Reduced-Fat/Reduced-Calorie Food James O. Hill · Nutrition Today Sep 2014 0
26 Novel vitamin B6 derivative of alendronate rapidly absorbed following oral administration Shawn Patrick Zinnen, David P. Sebesta, Alexander M. Karpeisky et al. · Bone 14 Feb 2006 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.